Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo express the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates by unknown
Mouse Bone Marrow-derived Mast Cells  (mBMMC) 
Obtained In Vitro from Mice That Are  Mast 
Cell-deficient In Vivo Express the Same Panel of 
Granule Proteases  as mBMMC  and Serosal Mast Cells 
from Their Normal Littermates 
By Karl K. Eklund,  Namit Ghildyal, K.  Frank Austen, 
Daniel S. Friend, Vera Schiller, and Richard L. Stevens 
From the Department of Medicine, Harvard Medical School; and the Departments of 
Rheumatology  and Immunology,  and Pathology, Brigham  and  Women's Hospital, Boston, 
Massachusetts 02115 
Summary 
The ear, skin, and purified serosal mast calls of WBB6F1/J-+/+  (WB-+/+) and WCB6Ft/J- 
+/+ (WC- +/+) mice contain high steady-state levels of the transcripts that encode mouse mast 
cell protease (mMCP) 2, mMCP-4, mMCP-5, mMCP-6, and mouse mast cell carboxypeptidase 
A (mMC-CPA). In contrast, no mast cell protease transcripts  are present in abundance in the 
ear and skin of WBB6F1/J-W/W  v (W/W v) and WCB6F1/J-SI/S1 d (SI/SI  a) mice which are mast 
cell-deficient in vivo due to defects in their c-kit and c-kit ligand genes, respectively. We now 
report that the immature bone marrow-derived mast cells (mBMMC) obtained in vitro with 
recombinant interleukin 3 (rIL-3) or WEHI-3 cell conditioned medium from WB-+/+, WC- 
+/+,  W/W ~, and SI/SI  d mice all contain high steady-state levels of the mMCP-2, mMCP-4, 
mMCP-5, mMCP-6, and mMC-CPA transcripts. As assessed immunohistochemically, mMCP-2 
protein and mMCP-5 protein are also present in the granules of mBMMC from WB-+/+, 
WC-+/+, and W/W ~ mice. That SI/SI  d and W/W ~ mBMMC contain high steady-state levels 
of five granule protease transcripts expressed by the mature serosal, ear, and skin mast cells of 
their normal +/+  littermates suggests that c-kit-mediated  signal transduction is not essential 
for inducing transcription  of these protease genes. Because rlL-4 inhibits  the rlL-10-induced 
expression of mMCP-1 and mMCP-2 in BALB/cJ mBMMC, the ability of rlL-4 to influence 
protease  mRNA  levels in  WC-+/+  mBMMC  and  W/W ~ mBMMC  was  investigated. 
Although rlL-10  induced expression  of the mMCP-1  transcript  in  WC-+/+  and  W/W ~ 
mBMMC, rIL-4 was not able to suppress the steady-state levels of the mMCP-1 transcript  or 
any other protease transcript in these cuhured mast cells. Thus, not only do BALB/cJ mBMMC 
express fewer granule proteases than mBMMC from mast cell-deficient strains and their normal 
littermates but the subsequent  induction of late-expressed proteases in BALB/cJ mBMMC is 
more tightly regulated by IL-3 and IL-4. 
W 
'hen bone marrow cells from the BALB/cJ mouse are 
cultured in the presence of recombinant (r)IL-3 or 
conditioned medium containing IL-3, immature mouse bone 
marrow-derived mast cells (mBMMC)  1 are obtained (1, 2) 
l~hat have high steady-state levels of the transcripts  that en- 
1 Abbreviations used in this paper: CTMC, connective tissue mast cells; KL, 
c-kit iigand;  mBMMC,  mouse bone marrow-derived mast cells; mMC- 
CPA, mouse mast  cell carboxypeptidase  A; mMCP,  mouse mast  cell 
protease; PTB, PBS/Tween-20/BSA;  r, recombinant;  SMC, serosal mast 
cells; WCM, WEHI-3 cell conditioned medium. 
code mouse mast cell protease (mMCP) 5 (3), mMCP-6 (4), 
and mouse mast cell carboxypeptidase A (mMC-CPA) (5). 
BALB/cJ mBMMC exposed to recombinant c-kit ligand (rKL), 
a fibroblast-derived cytokine (6), have high steady-state levels 
of the mMCP-4 transcript in addition to the other protease 
transcripts  (7). BALB/cJ mBMMC exposed concomitantly 
to rKL and either rlL-9 or rlL-10 contain high steady-state 
levels of the mMCP-1 and mMCP-2 transcripts in addition 
to the mMCP-4 transcript (8). However, the ability of rKL, 
rlL-9, or rlL-10 to induce BALB/cJ mBMMC to accumulate 
high  steady-state  levels of the  mMCP-1,  mMCP-2,  and 
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concomitantly to either rlL-3 or rlL-4 (7-11). 
The  WCBF~/J-SI/SI a  (SI/SI  d)  and  WBB6Ft/J-W/W  v 
(W/W v) mouse strains  possess abnormalities in the mem- 
brane-spanning domain of KL (6,  12) and the tyrosine ki- 
nase domain of c-kit (the membrane receptor for KL) (13), 
respectively.  Both strains normally have very few mast cells 
in their tissues (14-16), and the levels of all mMCP transcripts 
in their ears and skin are below detection (17) even though 
large numbers of mBMMC can be generated by culturing 
the hematopoietic progenitor cells of these mice in the pres- 
ence ofrlL-3 or IL-3-enriched conditioned medium (18). Con- 
nective tissue-type mast cells (CTMC) can be elicited in the 
skin of the W/W v mouse but not in the SI/SI  d mouse at sites 
of idiopathic chronic dermatitis (19) or by repeated applica- 
tion  of phorbol  ester  (20).  Because  W/W ~ mice  recon- 
stituted with mBMMC derived from the WBB6F1/J- +/+ 
(WB- +/+) mouse can produce cells at different anatomical 
sites that histochemically resemble either CTMC, serosal mast 
cells (SMC),  or mucosal mast cells (21), it was concluded 
that in the BALB/cJ mouse mMCP-5 (3, 22), mMCP-6 (4), 
and mMC-CPA (5)  are  early-expressed  proteases and that 
mMCP-1 (23,  24),  mMCP-2 (25),  and mMCP-4 (26)  are 
late-expressed  proteases.  In addition, because rKL-developed 
mBMMC histochemically  resemble SMC and CTMC, pref- 
erentially synthesize heparin proteoglycans, and contain high 
steady-state levels of the mMCP-4 transcript (7, 27),  it was 
concluded that KL and its receptor preferentially induce mast 
cell-committed progenitor cells to differentiate in a SMC 
and/or CTMC lineage. 
In the present study, mBMMC were developed with rlL-3 
or with IL-3-enriched WEHI-3 cell conditioned medium 
(WCM) in the absence of KL from mast cell-deficient strains, 
their +/+  littermates, BALB/cJ mice, and C57BL/6J mice. 
We now report that KL and its receptor are not essential 
for inducing expression  of those granule proteases  that are 
specifically found in SMC and CTMC. 
Materials and Methods 
Cell Culture.  mBMMC were obtained by separately culturing 
bone marrow cells from the femurs and tibias of BALB/cJ, WB- 
+/+,  WCB6F1/J-+/+  (WC-+/+),  W/W ~,  SI/SI  a,  and 
C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) for 
2-5 wk in enriched  medium (RPMI 1640 containing  0.1 mM nones- 
sential amino acids, 2 mM 1.-glutamine, 10% FCS [GIBCO BRL, 
Gaithersburg, MD], 100 U/ml penicillin, 100 gg/ml streptomycin, 
10 t~g/rrd gentamicin, and 50 gM 2-mercaptoethand) supplemented 
with either 100 U/m1 mouse rlL-3 (Genzyme Corp., Boston, MA) 
or 50% WEHI-3 cell (line TIB-68; American Type Culture Col- 
lection, gockville, MD) CM (1, 2). As assessed by PCR analysis, 
WEHI-3 cells do not express KL (Cheng, H.J., andJ. G. Flanagan, 
unpublished observation). Every 7 d, the nonadherent cells in the 
cultures were transferred into new flasks containing fresh culture 
medium. In some experiments, 3-wk-old mBMMC from BALB/cJ, 
WB-+/+, or WC-+/+  mice were separately cultured for 72 h 
in 50%  WCM/50% enriched medium supplemented with 100 
U/ml mouse rIL-10  alone or with both 50 U/ml mouse rIL-4 (Gen- 
zyme Corp.) and mouse rIL-10 (8-11). The concentration sdected 
for each cytokine was identical to or higher than that which was 
previously shown to elicit fully a particular biologic response in 
mouse mast cells. 
Histackemical, Immunokistockemical, Histamine, and mRNA Anal- 
yses of mBMMC.  Cytocentrifuge preparations of mBMMC ex- 
posed to various combinations of cytokines were stained with to- 
luidine blue or with alcian blue followed by saffanin (28). More 
than 100 cells were assessed histochemically in each experiment. 
For immunohistochemical analysis,  mBMMC in Carnoy's fixative 
were washed with PBS containing 0.2% Tween-20 and 0.1% BSA 
(PTB buffer), incubated for 30 min at 37~  in PBS containing 
0.05% Tween-20 and 4% goat serum, and then incubated for 2 h 
at 21~  with a~nity-purified anti-mMCP-2(56~n) IgG (11) or anti- 
mMCP-5046q6z) IgG (29) diluted in goat serum. The cells were 
washed in PTB buffer, incubated for 1 h at room temperature in 
PTB buffer supplemented with biotinylated goat anti-rabbit IgG, 
washed again, incubated  in the alkaline  phosphatase  Vectastain  ABC 
reagent (Vector Laboratories  Inc., Burlingame, CA) for 30 rain at 
room temperature, and then washed again in PTB buffer. In each 
protocol, control cell preparations were processed without primary 
antibodies. 
For histamine analyses, cells were suspended in HBSS at a den- 
sity of m5  x  106 cells/ml and then were sonicated at 4~  with 
a Branson Sonifier (15 pulses/50% pulse cycle;  Branson Ultrasonics 
Corp., Danbury, CT). The resulting  cell  lysates  were diluted 1/1,000 
in HBSS, and their histamine contents were determined with a 
radioimmunoassay kit (Amac Inc., Westbrook, ME) (30). 
For  quantitation  of  steady-state protease mRNA  levels in 
mBMMC, approximately  equal amounts of  total cellular  RNA (iso- 
lated by the method of  Chomczynski and Sacchi [31]) were applied 
to individual lanes of 1.3% agarose-formaldehyde  gels, and the gels 
were subjected to electrophoresis for 16-22 h. The separated  RNA 
was transferred to nylon membranes (MagnaGraph; Micron Sepa- 
rations Inc., Westboro, MA) (32). The resulting blots were ana- 
lyzed with [32p]dCTP (,,o3,000 Ci/mmol; DuPont/New England 
Nuclear, Boston, MA) random prime-labeled (Stratagene, La  Jolla, 
CA) mMCP-1 (9, 24), mMCP-2 (25), mMCP-4 (9, 26), mMCP-5 
(3), mMCPo6 (4), mMC-CPA (5), serglycin  proteoglycan peptide 
core (33), and 3-actin (34) cDNA probes. Hybridizations were per- 
formed at 68~  for 1--4 h with QuikHyb (Stratagene). The RNA 
blots were washed at 55-60~  in 30 mM NaC1, 3 mM sodium 
citrate, 0.1% SDS, and autoradiography  was performed  with Kodak 
XAR-5 film (Eastman Kodak Co., Rochester, NY). Usually, the 
same blot was assessed for the presence of other transcripts after 
the previous radiolabeled probe was removed by incubation of the 
blot for 1 h at 75~  in 0.25 mM EDTA, 0.1x  Denhardt's solu- 
tion, 5 mM Tris-HC1, and 0.05% pyrophosphate. In some cases, 
relative levels of individual transcripts were quantitated by directly 
measuring the amount of blot-bound radioactivity with a 32p im- 
aging system  (Betascope  603; IntelliGenetics,  Inc./Betagen, Moun- 
tain View, CA). The data were then B-actin corrected for variable 
total RNA loading in the lanes of the gel. 
The mMCP-4 probe used in the above RNA blot analyses  cross- 
reacts weakly (9) with a gene that encodes a mast cell-like serine 
protease that has been designated mMCP-L (26). Thus, a RNase 
protection analysis  was performed to confirm the presence of the 
mMCP-2 and mMCP-4 transcripts in WB-+/+  mBMMC. An- 
tisense cRNA probes corresponding to residues 804-956 of a 
mMCP-2 cDNA and residues 497-633 ofa mMCP-4 cDNA were 
generated from their plasmids with T3 or T7 primers and a kit 
from Ambion Inc. (Austin, TX). Each clLNA probe was labeled 
with [32p]dUTP (m800 Ci/mmol; DuPont/New England Nu- 
clear) and was then separately incubated overnight at 43~  with 
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+/+  mBMMC. The sizes of the protected fragments were ana- 
lyzed on 6%  polyacrylamide/8  M urea gels. 
Results 
Protease mRNA Levels in mBMMC Generated  from Different 
Strains.  4-wk-old IL-3-dependent mBMMC from BALB/cJ 
mice  contained  high  steady-state  levels  of the  mMCP-5, 
mMCP-6, and mMC-CPA transcripts but undetectable levels 
of the mMCP-1,  mMCP-2,  and mMCP-4 transcripts  (Fig. 
1). mBMMC generated from W/W ~ mice, SI/S1  a mice, and 
their  +/+  littermates contained not only high steady-state 
levels of the mMCP-5, mMCP-6, and mMC-CPA transcripts 
but also high steady-state levels of the mMCP-2 and mMCP-4 
transcripts. The presence of the mMCP-2 and mMCP-4 tran- 
scripts in WB- +/+  mBMMC was confirmed by KNase pro- 
tection assays. Total RNA from these mBMMC  protected 
a radiolabeled 136-bp fragment  of the mMCP-4 probe and 
a 152-bp fragment of the mMCP-2 probe from degradation 
(data not shown). C57BL/6J mBMMC contained high steady- 
state levels of the mMCP-5, mMCP-6, and mMC-CPA tran- 
scripts but not the mMCP-1,  mMCP-2,  or mMCP-4 tran- 
scripts  (data  not  shown). 
mBMMC from WB- +/+  mice and BALB/cJ mice were 
assessed for their histochemistry and time course of appear- 
ance of the  steady-state levels  of the mMCP-2,  mMCP-4, 
mMC-CPA, and serglycin transcripts.  No cells in the starting 
bone marrow from either strain stained with toluidine blue; 
only a few stained with  toluidine blue at  day 3.  However 
at day 10, 40-60% of the cells in the cultures from both strains 
contained metachromatic granules when stained with tolu- 
idine blue. The serglycin transcript was detected in the starting 
bone marrow cells from both strains (Fig.  2), but the steady- 
state level of this transcript was notably higher at day 3 and 
the level of this proteoglycan peptide core transcript remained 
very high throughout the subsequent 28 d of culture. A sub- 
stantial  increase in the steady-state level  of the mMC-CPA 
transcript also occurred at day 3. No mMCP-2 or mMCP-4 
transcripts were detected in the BALB/cJ mBMMC cultures 
at days 0,  3,  7,  10,  14,  21,  and 28.  In contrast,  WB-+/+ 
mBMMC  contained  detectable  steady-state  levels  of  the 
Figure  1.  KNA blot analyses 
of the steady-state levels of the 
mMCP-1, mMCP-2, mMCP-4, 
mMCP-5, mMCP-6,  mMC-CPA, 
and B-actin transcripts in mBM- 
MC derived by culturing bone 
marrow cells  from BALB/cJ  (lane 
1), WB-+/+ (lane2), WC-+/+ 
(lane 3),  SI/SI  d (lane 4),  and 
W/W  v (lane 5) mice for 4 wk in 
enriched medium supplemented 
with 100 U/ml rll~3. Similar  data 
were obtained in a repeat experi- 
ment, and in two additional ex- 
periments with mBMMC  derived 
with WCM rather than rlL-3. 
Figure 2.  R.NA  blot analyses  of the steady-state  levels  of  the mMCP-2, 
mMCP-4, mMC-CPA, and serglycin  (SG-PG) transcripts in starting bone 
marrow cells from BALB/cJ  mice (lane I) and WB-+/+  mice (lane 2); 
bone marrow cells from BALB/cJ  mice cultured for 3 d (lane  3), 7 d (lane 
5), 10 d (lane 7), 14 d (lane 9), 21 d (lane 11), and 28 d (lane 13) in the 
presence of WCM; and bone marrow cells  from WB- +/+ mice  cultured 
for 3 d (lane 4), 7 d (lane 6), 10 d (lane 8), 14 d (lane 10), 21 d (lane 
12), and 28 d (lane 14) in the presence of WCM. Similar data were ob- 
tained in two repeat experiments of 10- and 14-d duration. 
mMCP-2 transcript  at day 3, moderate levels at day 7, and 
maximal levels at days 10-14. The mMCP-4 transcript  was 
detected in  cultures  of WB-+/+  mBMMC at  day 7,  but 
maximal levels of this protease transcript  were not detected 
until  day 14. 
Histochemistry, Immunohistochemistry, and Histamine Content 
of mBMMC from Different Strains.  Whether  grown in the 
presence of rlL-3 or WCM, mBMMC from BALB/cJ, WB- 
+/+,  WC-+/+,  SI/SI  a,  W/W ~, and C57BL/6J mice were 
alcian  blue +/safranin-  when  stained,  suggesting  that  the 
mBMMC from these strains exhibit no substantial difference 
in the amount of heparin they synthesize. Whether derived 
with rlL-3 or WCM, mBMMC from BALB/cJ, WB- +/+, 
WC-+/+,  SI/SI  a,  or  W/W"  mice  all  contained  <300  ng 
histamine/106  cells.  The  mean  percentages  of mBMMC 
(>325 cells examined in each strain)  that reacted with anti- 
mMCP-5046-t62  ) IgG were 63% for WC- +/+  (Fig. 3), 23% 
for WB-+/+  (data not shown),  65%  for  W/W"  (Fig.  3), 
and 54%  for BALB/cJ (Fig.  3) mice. Whereas  53, 48, and 
72% of the mBMMC from the WC- +/+,  WB- +/+,  and 
W/W ~ strains,  respectively, reacted with anti-mMCP-21s6-7t) 
IgG,  only  1%  of the  mBMMC  from  the  BALB/cJ  and 
C57BL/6J mouse strains reacted with mMCP-2.  Approxi- 
mately 1% of the mBMMC in all preparations were reactive 
when incubated without  primary anti-mMCP-2/56-Tt)  IgG, 
or without  primary  anti-mMCP-5046-t62 ) IgG. 
Effects of Stimulatory and Inhibitory  Cytokines on the Steady- 
State  mMCP  mRNA  Levels  in  mBMMC from  WB-+/+, 
W/W ~,  and BALB/cJ  Mice.  Since  it  had  been previously 
shown that rlL-10 induces and rlL-4 suppresses the expres- 
sion  of mMCP-1  and  mMCP-2  in  BALB/cJ  mBMMC, 
mBMMC from WB-+/+  and  W/W ~ mice were exposed 
to WCM and rlL-10 in the presence or absence of rlL-4 to 
assess the ability of these two recombinant cytokines to alter 
protease expression. After exposure to rlL-10 for 72 h, both 
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MC, obtained  by culturing  progenitor  cells  for 3 wk 
in WCM, were stained  with anti-mMCP-2(s~_~)  IgG 
(panels a,  c,  and e)  or  anti-mMCP-5(l~,-l~2) IgG 
(panels b, d, andJ). The red alkaline  phosphatase  im- 
munoreaction product overlies mast cell granules 
(panels a, b, d, e, andJ). BALB/cJ  mBMMC  do not 
react with anti-mMCP-21s,-71) (panel c). WB-+/+ 
mBMMC (not shown) react in the same manner as 
WC-+/+ and W/W~-mBMMC. 
BALB/cJ mBMMC and WB- +/+ mBMMC contained high 
steady-state levels of the mMCP-1 and mMCP-2 transcripts 
(Fig. 4, lanes 2 and 5). In the depicted experiment, the levels 
of  the  mMCP-1,  and  mMCP-2  transcripts  in  BALB/cJ 
mBMMC exposed concomitantly  to WCM, rlL-10, and rlL-4 
(lane 3) were 55 and 64% less, respectively,  than the levels 
in BALB/cJ mBMMC exposed to WCM and rlL-10 (lane 
2). In contrast, the level of the mMCP-1 and mMCP-2 tran- 
scripts in WB-+/+  mBMMC exposed concomitantly to 
WCM, rlL-10, and rlL-4 (lane 6) were only 3 and 9% less, 
respectively,  than the levels in WB- +/+  mBMMC exposed 
to WCM and rlL-10 (lane 5). In a second experiment, the 
level of mMCP-1 mtLNA in BALB/cJ mBMMC was 51% 
less when the cells were exposed concomitantly to WCM, 
rlL-10, and rlL-4 than when they were exposed to WCM 
and rlL-10; there was no decrease in the level of this protease 
transcript in WB- +/+ mBMMC exposed concomitantly  to 
WCM, rlL-10, and rIL-4. Similar findings were obtained in 
a third experiment with W/W  v mBMMC (data not shown). 
Thus, as it did in BALB/cJ mBMMC, rIL-10 induced high 
steady-state levels of the mMCP-1 transcript in  W/W  ~ and 
WB- +/+ mBMMC. However, unlike its effect on BALB/cJ 
mBMMC, rIL-4 was not able to suppress  the level of the 
induced mMCP-1 and constitutive mMCP-2 transcripts in 
mBMMC obtained from the W/W  ~ and WB- +/+  strains. 
To assess further the ability of rIL-4 to regulate protease levels 
in WB- +/+  mBMMC, these cells were cultured for an ad- 
ditional 2 wk in the presence of rlL-3 alone or in the pres- 
ence of both rlL-3 and rIL-4. In two separate experiments, 
Figure  4.  RNA blot analyses  of the effect of rlh.4 on the rlL-10-in- 
duced expression of mMCP-1 and mMCP-2 in mBMMC. BALB/cJ 
mBMMC (lanes  I-3) and WB-+/+ mBMMC  (lanes  4--6) were  cultured 
for an additional  72 h in WCM alone  (lanes 1 and 4), WCM supplemented 
with rIL-10  (lanes  2 and 5), or WCM supplemented  with rib10 and rlL-4 
(lanes 3 and 6).  W/W ~ BMMC (not shown) react in the same manner 
as WB- +/+  mBMMC. 
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of the mMCP-2 or mMCP-4 transcripts in the cells of this 
strain  (data not shown). 
Discussion 
BALB/cJ mouse SMC express mMCP-4 but not mMCP-1, 
whereas BALB/cJ mouse mucosal mast cells express mMCP-1 
but not mMCP-4 (9, 22-24).  We previously reported that 
rlL-10-treated BALB/c mBMMC express high steady-state 
levels of the mMCP-1 transcript but not the mMCP-4 tran- 
script (9), whereas KL-treated mBMMC express the same 
pand of proteases as SMC, induding mMCP-4 (7). Because 
W/W ~ and Sl/Sl  a mice do not contain appreciable numbers 
of SMC (15), it was concluded that c-kit receptor and its ligand 
induce mast ceU-committed  progenitor calls to differentiate 
in a SMC lineage. We report in this study that mBMMC 
developed from W/W ~ mice, SI/SI  d mice, and their +/+  lit- 
termates differ from mBMMC developed from C57BL/6J 
mice and BALB/cJ mice in that they additionally have high 
steady-state levels of mMCP-2 and mMCP-4 transcripts (Fig. 
1) and mMCP-2 protein (Fig. 3). High steady-state levels of 
the mMC-CPA and scrglydn transcripts were obtained 3 d 
after bone marrow cells from WB-+/+  and BALB/cJ mice 
were exposed to WCM. WB- +/+ mBMMC contained mea- 
surable levels of the mMCP-2 and mMCP-4 transcripts  at 
day 7 and maximal levels at day 14. However, even at day 
28, the steady-state levels of the mMCP-2 and mMCP-4 tran- 
scripts were below detection in BALB/cJ mBMMC (Fig. 2). 
The observation  that  W/W ~ and Sl/Sl  d mBMMC express 
every protease that is found in the SMC of their normal +/+ 
littermates (Fig. 1) now indicates that c-kit-mediated  signal 
transduction is not essential for inducing transcription  of 
SMC-specific protease genes. 
It was previously shown that rKL dicits the expression 
of mMCP-4 in BALB/cJ mBMMC (7), whereas rlL-9 or 
rIL-10 in the presence ofrKL dicit the expression of mMCP-1 
and mMCP-2 in these cells (8). When present concomitantly, 
rIL-3 and rlL-4 each suppress the rIL-9-induced accumula- 
tion of the mMCP-1 and mMCP-2 transcripts and the rKL- 
induced accumulation of the mMCP-4 transcript in BALB/cJ 
mBMMC (7, 8). Although mBMMC from the WB-+/+ 
and WC-+/+  strains constitutively express mMCP-2 and 
all of the other granule proteases of SMC, they still require 
rlL-10 to induce the mucosal mast call-specific protease (23) 
mMCP-1 (Fig. 4). rlL-4 was not able to suppress the rlL- 
10-induced expression of the mMCP-1 transcript  in WC- 
+/+  mBMMC and W/W ~ mBMMC or any other protease 
transcript  in these mast cells (Fig. 4). The resistance of the 
mBMMC from the W/W ~, SI/SI  d, and  +/+  strains to the 
suppressive effects of rlL-3 and rlL-4 could be explained by 
a difference in the mast call-committed progenitor ceUs in 
their bone marrows. During the first week of culture of  bone 
marrow cells in the presence of rIL-3 or WCM, mast cells 
are a small proportion of the total cells in the culture (1, 2, 
18). Thus, an alternative explanation  for the expression of 
mMCP-2 and mMCP-4 in WB- +/+  mBMMC and WC- 
+/+ mBMMC is that the contaminating cell types present 
during the first week of culture of the ceUs from these strains, 
but not from the BALB/cJ strain, release factors that are able 
to counteract the suppressive effects of IL-3 and IL-4 on the 
expression of certain proteases. If so, it is unlikely that these 
autocrine factors include IL-9 or IL-10, inasmuch as mBMMC 
from the +/+  strains do not express mMCP-1 (Fig. 1) un- 
less they are exogenously stimulated  (Fig. 4). 
The SI/SI  a mouse and the W/W v mouse both have sub- 
stantially diminished numbers of mast cells in their tissues. 
The SI/S1  a mouse does not produce the membrane-bound 
form of KL (6,  12) and the W/W ~ mouse possesses an al- 
tered c-kit (13). The daily administration of 30 ~g/kg of rat 
rKL to WC- +/+  mice and SI/SI  a mice produces a dramatic 
increase in  the number of dermal mast cells (35). Thus, 
whether acting directly or indirectly,  KL is an important 
regulatory cytokine for this mast cell subclass in vivo. That 
bone marrow cells from both mast cell--deficient  mouse strains 
give rise to large numbers of mBMMC in vitro (18) indicates 
that these mice do not have  reduced numbers of  mast cell--com- 
mitted progenitor cells. Furthermore, mBMMC from both 
SI/SI  a  mice  and  W/W v  mice are  indistinguishable  from 
mBMMC of their +/+  littermates in terms of their expres- 
sion of high steady-state levels of the mMCP-2, mMCP-4, 
mMCP-5, mMCP-6, and mMC-CPA transcripts  (Fig. 1). 
Thus, mBMMC obtained from SI/SI  a and W/W ~ mice with 
WCM or with rIL-3 alone express the five granule proteases 
found in the SMC and CTMC of their  +/+  littermates. 
Gordon and Galli (20) reported that substantial numbers of 
mast cells can be elicited in the phorbol ester-treated skin 
of the W/W ~ mouse but not the skin of the SI/SI  d mouse. 
In addition,  Ody et al. (36) reported that normal numbers 
of mature safranin + mast  cells appear in  the skin  of the 
W/W ~ mouse when high concentrations  of rIL-3  are per- 
fused  into  the peritoneum continuously for  28  d.  That 
W/W ~ mBMMC  contain high  steady-state  levels of five 
granule protease transcripts  expressed by mature SMC and 
CTMC of their normal +/+ littermates suggests that in this 
strain, IL-3 can compensate for the signal transduction ab- 
normality in c-kit to promote the viability  and differentia- 
tion of progenitor ceUs  into mast cells that exhibit the granule 
protease phenotype of SMC and CTMC. Nevertheless, the 
failure to elicit mast cells in inflammatory sites in the skin 
of the SI/Sl  a mouse suggests that c-kit and its ligand are es- 
sential for the homing, retention, and/or life span of mast 
cell--committed progenitors in the skin. 
The mouse IL-10 cDNA used to obtain IL-10 in COS cells was generously provided by Dr. K. W. Moore 
(DNAX Research Institute, Palo Alto, CA). 
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